http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004242550-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
filingDate | 2002-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c19f078cf21a0451d87e385d9511fd0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a284d0e4f0aed22b60887c1adb50e5bc |
publicationDate | 2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2004242550-A1 |
titleOfInvention | Means and method for hormonal contraception |
abstract | The present invention is concerned with a kit containing a plurality of hormone units for use in a contraceptive method which consists of two alternating consecutive phases, sometimes referred to as a sequential method or sequential regimen. More particularly the present invention relates to a kit containing a plurality of daily hormone units for use in a contraceptive method which consists of two alternating consecutive phases—an estrogenic and a progestogenic phase—of administering a sequence of said hormone units to a female of childbearing capability, the plurality of daily hormone units consisting of: (a) one or more daily hormone units, for use during the estrogenic phase, containing synthetic estrogen or a combination of synthetic estrogen and biogenic estrogen in a therapeutically effective amount to inhibit ovulation and (b) at least 10 daily hormone units, for use during the progestogenic phase, containing a combination of biogenic estrogen and progestogen in a therapeutically effective amount to inhibit ovulation and to transform the endometrium from a proliferative into a secretory state. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010021529-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011172197-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008021003-A1 |
priorityDate | 2001-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 338.